Here are four things to know about the deal:
1. Aquiline Capital Partners is a private equity firm based in New York City. Aspirion, founded in 2012, is a revenue cycle management company offering complex claims solutions to U.S. healthcare organizations.
2. Through the acquisition, Aquiline will support Aspirion’s growth and allow it to expand its product offerings. The company’s clients include regional hospitals and physician groups, as well as large, multistate health systems.
3. Jeff Greenberg, chairman and CEO of Aquiline, said of the deal: “We have long viewed healthcare as a natural extension of Aquiline’s established expertise in the insurance, billing, and payments industries. Given Aspirion’s focus on payments from property and casualty payers, we are excited to leverage our deep experience with these payers to help Aspirion meet healthcare providers’ toughest revenue challenges, and we see significant opportunities to create growth.”
4. Lori Lipocky, CEO of Aspirion, helms the management team; Aquiline appointed healthcare veteran Michael O’Boyle executive chairman.
More articles on healthcare finance:
Houston surgical hospital abruptly closes after discovering accounting errors
California hospital avoids closure, enters 5-year management contract
Vanderbilt University Medical Center points to Epic rollout for 60% drop in operating income
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
